You just read:

Rigel to Provide Business Review and Updated Phase 2 Results for Fostamatinib in AIHA at the 36th Annual J.P. Morgan Healthcare Conference

News provided by

Rigel Pharmaceuticals, Inc.

Jan 04, 2018, 07:30 ET